Top

Published in:

Open Access 31-01-2024 | Tinnitus | Review Article

Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach

Author: Mina T. Kelleni

Published in: Inflammopharmacology | Issue 2/2024

Abstract

Chronic tinnitus is a common neurological disorder that affects millions of patients globally with no available successful pharmacotherapy. It can be extremely bothersome to some patients to the extent that it occasionally qualifies as a disability that can hinder them from leading a normal life. In this short communication, the author discusses how he suffered from idiopathic tinnitus and how he managed to adopt a combined pathophysiological and pharmacological approach to the reason for the first time in the medical literature that low-dose metformin might be safely and effectively repurposed to manage at least a subset of tinnitus patients while discussing the potential role of adenosine receptor agonists as potential future tinnitus therapeutics.

Aljuaid SM, Mirza AA, Habib LA, AlHarthi LA, Alansari BM, AlQahtani BG, Althobaiti YA (2020) Does caffeine intake increase the incidence of Tinnitus? A systematic review. Int Arch Otorhinolaryngol 25:e628–e632PubMedPubMedCentral

Bhatt IS, Wilson N, Dias R, Torkamani A (2022) A genome-wide association study of tinnitus reveals shared genetic links to neuropsychiatric disorders. Sci Rep 12:22511CrossRefPubMedPubMedCentral

Colizza A, Ralli M, Turchetta R, Minni A, Greco A, De Vincentis M (2022) Otolaryngology adverse events following COVID-19 vaccines. Eur Rev Med Pharmacol Sci 26:4113–4116PubMed

Dardennes R, Al Anbar N, Rouillon F (2013) Propofol-interrupted Tinnitus later suppressed by Amantadine: a case-report. J Clin Pharmacol 53:356–358CrossRefPubMed

Dattilo S, Mancuso C, Koverech G, Di Mauro P, Ontario ML, Petralia CC, Petralia A, Maiolino L, Serra A, Calabrese EJ, Calabrese V (2015) Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing 12:20CrossRefPubMedPubMedCentral

Degen CV, Mikuteit M, Niewolik J, Schröder D, Vahldiek K, Mücke U, Heinemann S, Müller F, Behrens GMN, Klawonn F, Dopfer-Jablonka A, Steffens S (2022) Self-reported Tinnitus and Vertigo or dizziness in a cohort of adult long COVID patients. Front Neurol 13:884002CrossRefPubMedPubMedCentral

Demaré S, Kothari A, Calcutt NA, Fernyhough P (2021) Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system. Expert Rev Neurother 21:45–63CrossRefPubMed

Elgandy MS and Coelho C (2022) Chapter 11. Tinnitus in children., In Tinnitus treatment : clinical protocols, Tyler RS and Perreau A (eds), Thieme Medical Publishers, Incorporated, NEW YORK, GERMANY

Figueiredo RR, Azevedo AAd and Penido NdO (2021) Chapter 16-Tinnitus features according to caffeine consumption, in Progress in Brain Research (Langguth B, Kleinjung T, De Ridder D, Schlee W and Vanneste S (Eds) Elsevier, pp 335–344

Figueiredo RR, Penido NdO, Azevedo AAd, Oliveira PMd, Siqueira AGd, Figueiredo GdMR, Schlee W, Langguth B (2022) Tinnitus emerging in the context of a COVID-19 infection seems not to differ in its characteristics from tinnitus unrelated to COVID-19. Front Neurol 13:674179CrossRef

Fuxe K, Marcellino D, Borroto-Escuela DO, Guescini M, Fernández-Dueñas V, Tanganelli S, Rivera A, Ciruela F, Agnati LF (2010) Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 16:e18–e42CrossRefPubMedPubMedCentral

Gander PE and Tyler RS (2022) Chapter 1. Neurophysiological models, psychological models, and treatments for Tinnitus., in Tinnitus treatment : clinical protocols (Tyler RS and Perreau A (Eds), Thieme Medical Publishers, Incorporated, NEW YORK, GERMANY

Gomaa AA, Abdel-Wadood YA, Gomaa MA (2022) Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment. Inflammopharmacology 30:1977–1992CrossRefPubMedPubMedCentral

Jacobson KA, Tosh DK, Jain S, Gao ZG (2019) Historical and current adenosine receptor agonists in preclinical and clinical development. Front Cell Neurosci 13:124CrossRefPubMedPubMedCentral

Kelleni MT (2020) Nitazoxanide/azithromycin combination for COVID-19: a suggested new protocol for early management. Pharmacol Res 157:104874CrossRefPubMedPubMedCentral

Kelleni MT (2022) NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Inflammopharmacology 30:343–348CrossRefPubMed

Kelleni MT (2023a) The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one. Inflammopharmacology 31:3335–3338CrossRefPubMedPubMedCentral

Kelleni MT (2023b) Real-life practice of the Egyptian Kelleni’s protocol in the current tripledemic: COVID-19, RSV and influenza. J Infect 86:154–225CrossRefPubMed

Kelleni MT (2023c) Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol. Inflammopharmacology 31:1559–1560CrossRefPubMedPubMedCentral

Kelly Radziwon, Sarah H. Hayes, Adam M. Sheppard, Dalian Ding and Salvi R (2015) Chapter 6. Drug induced Tinnitus, in Tinnitus: clinical and research perspectives (Fagelson M Ed), Plural, Publishing, Incorporated

Kim SH, Kim D, Lee J-M, Lee SK, Kang HJ, Yeo SG (2021) Review of pharmacotherapy for Tinnitus. Healthcare. https://doi.org/10.3390/healthcare9060779CrossRefPubMedPubMedCentral

Lentferink YE, Knibbe CAJ, van der Vorst MMJ (2018) Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs 78:1887–1901CrossRefPubMed

Li N, Zhou T, Fei E (2022) Actions of metformin in the brain: a new perspective of metformin treatments in related neurological disorders. Int J Mol Sci. https://doi.org/10.3390/ijms23158281CrossRefPubMedPubMedCentral

Lopez-Gonzalez MA, Esteban-Ortega F (2005) Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation. Med Hypotheses 65:349–352CrossRefPubMed

Paiva M, Riksen NP, Davidson SM, Hausenloy DJ, Monteiro P, Gonçalves L, Providência L, Rongen GA, Smits P, Mocanu MM, Yellon DM (2009) Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J Cardiovasc Pharmacol 53:373CrossRefPubMed

Ross AE, Venton BJ (2015) Adenosine transiently modulates stimulated dopamine release in the caudate–putamen via A1 receptors. J Neurochem 132:51–60CrossRefPubMed

Schloss JV (2023) Nutritional deficiencies that may predispose to long COVID. Inflammopharmacology 31:573–583CrossRefPubMedPubMedCentral

Srinivasan M (2012) Chapter 19. Tinnitus, in The patient history: an evidence-based approach to differential diagnosis, 2e (Henderson MC, Tierney LM and Smetana GW eds), The McGraw-Hill Companies, New York, NY

Trinidade A, Robinson T, Phillips JS (2014) The role of caffeine in otorhinolaryngology: guilty as charged? Eur Arch Otorhinolaryngol 271:2097–2102CrossRefPubMed

Wang YW, He SJ, Feng X, Cheng J, Luo YT, Tian L, Huang Q (2017) Metformin: a review of its potential indications. Drug Des Devel Ther 11:2421–2429CrossRefPubMedPubMedCentral

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Investig 108:1167–1174CrossRefPubMedPubMedCentral

Title: Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach
Author: Mina T. Kelleni
Publication date: 31-01-2024
Publisher: Springer International Publishing
Keywords: Tinnitus
Metformin
Long-COVID Syndrome
Published in: Inflammopharmacology / Issue 2/2024
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-023-01421-8

2024 ASCO Annual Meeting

Springer Medicine

Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2024

PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats

Anti-inflammatory potential of some eudesmanolide and guaianolide sesquiterpenes

Leaf extracts of eight selected southern African medicinal plants modulate pro-inflammatory cytokine secretion in LPS-stimulated RAW 264.7 macrophages

Quercetin attenuates Pseudomonas aeruginosa-induced acute lung inflammation by inhibiting PI3K/AKT/NF-κB signaling pathway

Correction: Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis

Flavipin from fungi as a potential inhibitor of rheumatoid arthritis signaling molecules